jackie_fouse_hires

Agios appoints Celgene’s Jacqualyn Fouse as new CEO

September 5, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, COO, Celgene, Jacqualyn Fouse, agios

The Massachusetts-based oncology specialist Agios Pharmaceuticals has appointed former Celgene President and COO Jacqualyn Fouse as their new Chief Executive …

shutterstock_206748499

FDA turns to real-world evidence to improve regulatory process

September 5, 2018
Medical Communications, Research and Development, Sales and Marketing FDA, pharma, real world data, real world evidence, real-world data, real-world evidence

The FDA has announced its intention to incorporate real-world data elements to a greater degree into its regulatory decision-making framework …

Puma Biotech’s breast cancer drug authorised by European Commission, despite prior concerns

September 5, 2018
Research and Development Cancer, EU, breast cancer, ec approval, puma biotechnology

Puma Biotechnology have received European Commission marketing authorisation for Nerlynx (neratinib) despite prior concerns as to the safety and efficacy …

Europe-wide policy could boost generics market, study suggests

September 5, 2018
Research and Development Europe, generics, growth, markets, pharma

A Europe-wide policy covering the generic pharmaceutical market would facilitate significant growth in the pharmaceutical sector according to a new …

Sanofi to pay $25m over Kazakhstan and Middle East corruption allegations

September 5, 2018
Research and Development Kazakhstan, SEC, Sanofi, allegations, corruption, middle east

French pharma giant Sanofi will pay more than $25 million to settle corruption charges related to their subsidiaries in Kazakhstan …

Novartis’ CAR T therapy Kymriah to become available on the NHS

September 5, 2018
Research and Development CAR T, CAR-T, Gilead, Kymriah, NHS, Novartis

Novartis’ Kymriah is set to become the first CAR T therapy to become available on the NHS after it was …

melanie_lee_770x510

UK research charity LifeArc appoints experienced leader Melanie Lee as new CEO

September 4, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, melanie lee

The life sciences medical research charity LifeArc, formerly MRC Technology, has appointed Dr Melanie Lee as its new Chief Executive …

dia_logo

DIA Value, Access, and Regulatory Conference 2018

September 4, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing dia, event, pharma

Dr Solange Corriol-Rohou, Senior Director, Global Regulatory Affairs & Policy, Europe, at AstraZeneca Global Medicines Development, discusses DIA’s upcoming Value, …

European Commission authorises first-ever rare blood condition drug

September 4, 2018
Manufacturing and Production, Sales and Marketing Europe, Sanofi, approvals, cablivi, eu commission

Sanofi have announced that the European Commission granted marketing authorisation for Cablivi (caplacizumab) for the treatment of adults experiencing an …

janssen_latest_logo_on_sign

Europe approves Janssen’s Darzalex in frontline multiple myeloma

September 4, 2018
Manufacturing and Production, Research and Development, Sales and Marketing EU, Europe, J&J, JJ, Janssen, darzalex, multiple myeloma, pharma

Janssen has revealed that its CD38-targeting biologic drug Darzalex (daratumumab) has received approval from the European Commission, authorising its use …

Pfizer says Brexit will cost the company $100 million

September 4, 2018
Manufacturing and Production EU, Pfizer, UK, brexit, pharma

The US multinational Pfizer has said that Brexit will cost the company $100 million in costs associated with the transference …

371628984_a662993bf6_z

Antibiotic combinations could help in fight against antimicrobial resistance

September 4, 2018
Manufacturing and Production AMR, Antibiotics, antibiotic resistance, e coli, ucla

Antimicrobial resistance (AMR) could be tackled by giving people a combination of antibiotic drugs that are no longer effective on …

Faubel-Booklet Labels

September 3, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Faubel-Booklet Labels with temperature indicators from ELPRO identify and monitor pharmaceutical products Melsungen, 3rd of September 2018Pharmaceutical products without proper …

shutterstock_192094955_web

Widening the focus on innovations in cancer treatment

September 3, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, CRUK, Cancer, GSK, diagnosis, genetics, oncology, pharma

Cancer treatment is making leaps and bounds, but public focus tends to gravitate towards the therapies themselves. Matt Fellows explores …

5204602349_c87b204860_z

FDA rejects Sunovion’s ADHD drug dasotraline

September 3, 2018
Sales and Marketing ADHD, FDA, dasotraline, drug, sunovion

The US Food and Drug Administration (FDA) have rejected American pharma firm Sunovion’s application to market dasotraline for the treatment …

450px-academisch_medisch_centrum_amsterdam_001

Dutch doctors resist pharma firm’s 500-fold price hike

September 3, 2018
Sales and Marketing Netherlands, leadiant, pharma, pricing

A group of Dutch doctors and health advocates are taking action against the Italian pharmaceutical firm Leadiant Biosciences who have …

pharmafocus_oct_2018

The September 2018 issue of Pharmafocus is available to read online now!

September 3, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, AstraZeneca, Cancer, Iraw, J&J, JJ, Pfizer, Roche, UK, brexit, drug safety, pharma, pharmacovigilance

The new September edition of Pharmafocus is now live and available to read online. We’re entering the final stretch as …

AI used to forecast cancer progression

September 3, 2018
Sales and Marketing AI, Cancer, ICR, London, ai drug research and development, university of edinburgh

A team of scientists at the Institute of Cancer Research (ICR) in London and the University of Edinburgh have developed …

28246711066_52e38bc591_z

MHRA loses EMA contracts in wake of Brexit

September 3, 2018
Sales and Marketing EMA, MHRA, UK, brexit, contracts, politics, regulation

The EMA has awarded Britain’s regulatory body the MHRA just two contracts this year, as the European agency suggested that …

The Gateway to Local Adoption Series

Latest content